Want a biotech buyout? Target cancer
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hope you had a reflective Indigenous Peoples Day. Today, we talk about the implications of Bristol Myers Squibb acquiring Mirati Therapeutics, see a new lung cancer test from liquid biopsy player Delfi Diagnostics, and more.
Read Original Article: Want a biotech buyout? Target cancer »
